WARSAW, Ind., Dec. 13, 2016 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) (the “Company”) today announced that it has completed an offering of €500 million aggregate principal amount of 1.414% Notes due 2022 (the “2022 Notes”) and €500 million aggregate principal amount of 2.425% Notes due 2026 (together with the 2022 Notes, the “Euro Notes”) in an SEC registered offering. The Company […]